Abstract:Abstract Background Glioblastomas (GBMs) are grade IV central nervous system tumors characterized by a poor prognosis and a short median overall survival. Effective induction of GBM cell death is difficult because the GBM cell population is genetically unstable, resistant to chemotherapy and highly angiogenic. In recent studies, ubiquitin-specific protease 7 (USP7) is shown to scavenge ubiquitin from oncogenic protein substrates, so effective inhibition of USP7 may be a potential key treatment for GBM. Methods Immunohistochemistry and western blotting were used to detect the expression of USP7 in GBM tissues. In vitro apoptosis assay of USP7 inhibition was performed by western blotting, immunofluorescence, and flow cytometry. Anti-apoptotic substrates of USP7 were defined by Co-IP and TMT proteomics. Western blotting and IP were used to verify the relationship between USP7 and its substrate. In an in vivo experiment using an intracranial xenograft model in nude mice was constructed to assess the therapeutic effect of target USP7. Results Immunohistochemistry and western blotting confirmed that USP7 was significantly upregulated in glioblastoma samples. In in vitro experiments, inhibition of USP7 in GBM induced significant apoptosis. Co-IP and TMT proteomics identified a key anti-apoptotic substrate of USP7, ADP-ribosylation factor 4 (ARF4). Western blotting and IP confirmed that USP7 interacted directly with ARF4 and catalyzed the removal of the K48-linked polyubiquitinated chain that binded to ARF4. In addition, in vivo experiments revealed that USP7 inhibition significantly suppressed tumor growth and promoted the expression of apoptotic genes. Conclusions Targeted inhibition of USP7 enhances the ubiquitination of ARF4 and ultimately mediates the apoptosis of GBM cells. In a clinical sense, P5091 as a novel specific inhibitor of USP7 may be an effective approach for the treatment of GBM.

Overexpression of Ubiquitin Specific Proteases 44 Promotes the Malignancy of Glioma by Stabilizing Tumor-Promoter Securin.

Ubiquitin-specific Protease 22 Acts As an Oncoprotein to Maintain Glioma Malignancy Through Deubiquitinating B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 for Stabilization.

Ubiquitin‐specific Protease 44 Inhibits Cell Growth by Suppressing AKT Signaling in Non‐small Cell Lung Cancer

Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway

Identification of Ubiquitin-Specific Protease 32 As an Oncogene in Glioblastoma and the Underlying Mechanisms

Transcriptome Analysis and Single-Cell Sequencing Analysis Constructed the Ubiquitination-Related Signature in Glioma and Identified USP4 as a Novel Biomarker

Bulk and Single Cells Transcriptomes with Experimental Validation Identify USP18 As a Novel Glioma Prognosis and Proliferation Indicator

USP39-mediated deubiquitination of Cyclin B1 at Lys242 promotes tumor cell cycle G2/M transition and glioma progression

USP39-mediated Deubiquitination of Cyclin B1 Promotes Tumor Cell Proliferation and Glioma Progression

Deubiquitinase USP9X Deubiquitinates Β-Catenin and Promotes High Grade Glioma Cell Growth

Comprehensive Analysis of Ubiquitin‐specific Protease 1 Reveals Its Importance in Hepatocellular Carcinoma

Knockdown of Ubiquitin-Specific Peptidase 39 Inhibited the Growth of Osteosarcoma Cells and Induced Apoptosis in Vitro.

Downregulation of Ubiquitin-Specific Protease 14 (USP14) Inhibits Breast Cancer Cell Proliferation and Metastasis, but Promotes Apoptosis

Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.

USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1

USP10 promotes cell proliferation, migration, and invasion in NSCLC through deubiquitination and stabilization of EIF4G1

Ubiquitin-specific Protease 2a Stabilizes MDM4 and Facilitates the P53-Mediated Intrinsic Apoptotic Pathway in Glioblastoma.

USP7 Inhibition Induces Apoptosis in Glioblastoma by Stabilizing ARF4

USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression

Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC

USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4